Trial · NCT03129321
Results by group15
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 15 of 15
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Proportion of Patients in Each Active Treatment Group Who Are Considered a Therapeutic Cure | Test | 96 | Participants | ||
| Proportion of Patients in Each Active Treatment Group Who Are Considered a Therapeutic Cure | Reference Standard | 81 | Participants | ||
| Proportion of Patients in Each Treatment Group Who Are Considered a Therapeutic Cure | Test | 102 | Participants | ||
| Proportion of Patients in Each Treatment Group Who Are Considered a Therapeutic Cure | Reference Standard | 88 | Participants | ||
| Proportion of Patients in Each Treatment Group Who Are Considered a Therapeutic Cure | Placebo | 22 | Participants | ||
| Proportion of Patients in Each Active Treatment Group Who Are Considered a Clinical Cure (Patient's Total Severity Score Must be ≤ 2 With no Individual Severity Score > 1) | Test | 113 | Participants | ||
| Proportion of Patients in Each Active Treatment Group Who Are Considered a Clinical Cure (Patient's Total Severity Score Must be ≤ 2 With no Individual Severity Score > 1) | Reference Standard | 99 | Participants | ||
| Proportion of Patients in Each Active Treatment Group Who Are Considered a Mycological Cure | Test | 136 | Participants | ||
| Proportion of Patients in Each Active Treatment Group Who Are Considered a Mycological Cure | Reference Standard | 125 | Participants | ||
| Proportion of Patients in Each Treatment Group Who Are Considered a Clinical Cure (Patient's Total Severity Score Must be ≤ 2 With no Individual Severity Score > 1) | Test | 131 | Participants | ||
| Proportion of Patients in Each Treatment Group Who Are Considered a Clinical Cure (Patient's Total Severity Score Must be ≤ 2 With no Individual Severity Score > 1) | Reference Standard | 113 | Participants | ||
| Proportion of Patients in Each Treatment Group Who Are Considered a Clinical Cure (Patient's Total Severity Score Must be ≤ 2 With no Individual Severity Score > 1) | Placebo | 40 | Participants | ||
| Proportion of Patients in Each Treatment Group Who Are Considered a Mycological Cure | Test | 147 | Participants | ||
| Proportion of Patients in Each Treatment Group Who Are Considered a Mycological Cure | Reference Standard | 137 | Participants | ||
| Proportion of Patients in Each Treatment Group Who Are Considered a Mycological Cure | Placebo | 37 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03129321/results